The activation process of PZCT is controlled by a tumor-specific bioreciprocal mechanism overexpressing miR-21, which utilizes the catalytic action of Zn2+ to generate a large amount of DNAzymes, silencing EGR-1 mRNA, and thereby inhibiting tumor growth (Figure 12). The gene discussed is EGR1; the disease is neoplasm.